Cargando…
Neoadjuvant chemotherapy for colorectal liver metastases: A contemporary review of the literature
Colorectal carcinoma (CRC) is one of the leading causes of cancer-related deaths worldwide, and up to 50% of patients with CRC develop colorectal liver metastases (CRLM). For these patients, surgical resection remains the only opportunity for cure and long-term survival. Over the past few decades, o...
Autores principales: | Guo, Marissa, Jin, Ning, Pawlik, Timothy, Cloyd, Jordan M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465453/ https://www.ncbi.nlm.nih.gov/pubmed/34616511 http://dx.doi.org/10.4251/wjgo.v13.i9.1043 |
Ejemplares similares
-
Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma
por: Akateh, Clifford, et al.
Publicado: (2020) -
Resection of colorectal liver metastases following neoadjuvant chemotherapy
por: Chiappa, A, et al.
Publicado: (2007) -
Colorectal Liver Metastases
por: Haddad, Ashraf J., et al.
Publicado: (2011) -
Effect of Neoadjuvant Chemotherapy in Patients with Resectable Colorectal Liver Metastases
por: Zhu, Dexiang, et al.
Publicado: (2014) -
Molecular Mechanisms of Colorectal Liver Metastases
por: Tsilimigras, Diamantis I., et al.
Publicado: (2023)